The aim of this clinical study (EUDRACT Number 2010-020196-23) was to evaluate the effects of the recombinant FSH administration, 150 IU every other day in a 3-month time frame, on sperm DNA damage evaluated through DFI in male partners of infertile couples with low-normal FSH levels. This evidence concerns the gene BRD2 and Infertility.